UNSPSC 51343826: Sofosbuvir/Velpatasvir

Sofosbuvir/velpatasvir is a fixed-dose combination medication for the treatment of hepatitis C in adults.

UNSPSC 51343826 Sofosbuvir/Velpatasvir is a Commodity code identifying a specific antiviral pharmaceutical product, yet the recent state and local contract opportunities tagged with this code show no procurement activity for the drug itself. Instead, the opportunities reflect tangential health-related purchasing—oxygen rental, drug standards for forensic analysis, naloxone distribution, EMS pharmaceuticals and supplies, peer support services, and clinic wellness programs—none of which involve sofosbuvir/velpatasvir procurement. The mismatch between code label and actual solicitation content signals that this Commodity code captures little or no active state and local demand for the named pharmaceutical. State and local agencies purchasing sofosbuvir/velpatasvir would typically do so through existing pharmacy benefit programs, state Medicaid contracts, or county health department agreements rather than standalone solicitations tagged to the product-specific UNSPSC code. The tagging inconsistency reflects the broader challenge of aligning catalog-level drug codes with how government agencies actually procure specialty pharmaceuticals through consolidated vendor networks and existing agreements.

No active state and local solicitation for sofosbuvir/velpatasvir procurement was identified in the recent opportunities block. If a firm is pursuing state and local market share in hepatitis C treatment provision or pharmacy benefit management, success will depend on engagement with existing state Medicaid programs, pharmacy cooperative purchasing vehicles such as MMCAP (demonstrated in parallel opportunities for generic multi-source pharmaceuticals), and county health plan procurement channels rather than on response to UNSPSC-51343826-specific RFPs or ITBs. Geographic activity cannot be characterized from the available source material, as no relevant solicitations are present to establish jurisdictional concentration or buyer patterns.